Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Assets: 2009-2012

Historic Assets for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $357.8 million.

  • Lexicon Pharmaceuticals' Assets rose 21.42% to $357.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $357.8 million, marking a year-over-year increase of 21.42%. This contributed to the annual value of $430.5 million for FY2011, which is 17.34% up from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Assets stood at $357.8 million for Q3 2012, which was down 6.09% from $381.1 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' 5-year Assets high stood at $430.5 million for Q4 2011, and its period low was $223.7 million during Q3 2009.
  • For the 3-year period, Lexicon Pharmaceuticals' Assets averaged around $367.1 million, with its median value being $366.9 million (2010).
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Assets skyrocketed by 67.40% in 2010, and later decreased by 20.54% in 2011.
  • Over the past 4 years, Lexicon Pharmaceuticals' Assets (Quarterly) stood at $257.8 million in 2009, then spiked by 42.33% to $366.9 million in 2010, then increased by 17.34% to $430.5 million in 2011, then climbed by 21.42% to $357.8 million in 2012.
  • Its last three reported values are $357.8 million in Q3 2012, $381.1 million for Q2 2012, and $402.8 million during Q1 2012.